- Empagliflozin 12.5mg / Metformin 850mg tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Empagliflozin 12.5mg / Metformin 850mg tablets | Start Date 02-09-2015 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- A10BD20
BNF | Start Date | End Date |
---|---|---|
Current BNF 06010203 | Start Date 04-04-2022 | End Date |
Previous BNF 06010203 | Start Date 25-05-2016 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
30318211000001103 | 02-09-2015 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Empagliflozin | Based on Ingredient Substance | 12.5 mg | ||
Metformin hydrochloride | Based on Ingredient Substance | 850 mg |
Name
Metformin hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
850
Strength and UOM (Dmr)
Name
Empagliflozin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
12.5
Strength and UOM (Dmr)
Parent Products
-
VTMEmpagliflozin + Metformin
-
VMP(Current) Empagliflozin 12.5mg / Metformin 850...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
56 tablet | 3659 | Part VIIIA Category C |